Vincerx Pharma, Inc. Operating Income
Vincerx Pharma, Inc. reported Operating Income of -$3.33 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-05-15
- Vincerx Pharma, Inc. operating income (loss) for the quarter ending 2025-03-31 was -$3.33M.
- Vincerx Pharma, Inc. operating income (loss) for the quarter ending 2024-12-31 was -$8.83M.
- Vincerx Pharma, Inc. operating income (loss) for the quarter ending 2024-09-30 was -$7.79M.
- Vincerx Pharma, Inc. operating income (loss) for the quarter ending 2024-06-30 was -$7.37M.
- Vincerx Pharma, Inc. operating income (loss) for fiscal 2024 was -$31.46M.
- Vincerx Pharma, Inc. operating income (loss) for fiscal 2023 was -$42.61M.
- Vincerx Pharma, Inc. operating income (loss) for fiscal 2022 was -$71.19M.
- Vincerx Pharma, Inc. operating income (loss) for fiscal 2021 was -$62.66M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 10 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -$3.33M 10-Q · filed 2025-05-15 | -$12.16M derived: sum of 2 quarters · filed 2025-05-15 | -$19.95M derived: sum of 3 quarters · filed 2025-05-15 | -$27.32M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2024-12-31 | -$8.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$16.62M derived: sum of 2 quarters · filed 2025-03-27 | -$23.98M derived: sum of 3 quarters · filed 2025-03-27 | -$31.46M 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | -$7.79M 10-Q · filed 2024-11-12 | -$15.16M derived: sum of 2 quarters · filed 2024-11-12 | -$22.64M 10-Q · filed 2024-11-12 | -$28.17M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2024-06-30 | -$7.37M 10-Q · filed 2024-08-08 | -$14.84M 10-Q · filed 2024-08-08 | -$20.38M derived: sum of 3 quarters · filed 2025-05-15 | -$29.99M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2024-03-31 | -$7.48M 10-Q · filed 2025-05-15 | -$13.01M derived: sum of 2 quarters · filed 2025-05-15 | -$22.62M derived: sum of 3 quarters · filed 2025-05-15 | -$34.68M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$15.14M derived: sum of 2 quarters · filed 2025-03-27 | -$27.20M derived: sum of 3 quarters · filed 2025-03-27 | -$42.61M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | -$9.61M 10-Q · filed 2024-11-12 | -$10.32M 10-Q · filed 2023-11-14 | -$21.67M derived: sum of 2 quarters · filed 2024-11-12 | -$37.08M 10-Q · filed 2024-11-12 | -$50.12M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$12.06M 10-Q · filed 2024-08-08 | -$11.66M 10-Q · filed 2023-08-07 | -$27.47M 10-Q · filed 2024-08-08 | -$26.76M 10-Q · filed 2023-08-07 | -$40.51M derived: sum of 3 quarters · filed 2024-08-08 | -$57.41M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$15.41M 10-Q · filed 2024-05-14 | -$15.10M 10-Q · filed 2023-05-11 | -$28.45M derived: sum of 2 quarters · filed 2024-05-14 | -$45.35M derived: sum of 3 quarters · filed 2024-05-14 | -$64.97M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | -$13.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$29.94M derived: sum of 2 quarters · filed 2024-03-29 | -$49.56M derived: sum of 3 quarters · filed 2024-03-29 | -$71.19M 10-K · filed 2024-03-29 | -$73.57M 10-K · filed 2023-03-28 | |||
| 2022-09-30 | -$16.90M 10-Q · filed 2023-11-14 | -$36.52M derived: sum of 2 quarters · filed 2023-11-14 | -$58.15M 10-Q · filed 2023-11-14 | -$75.86M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$19.62M 10-Q · filed 2023-08-07 | -$41.25M 10-Q · filed 2023-08-07 | -$58.96M derived: sum of 3 quarters · filed 2023-08-07 | -$76.89M derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | -$21.63M 10-Q · filed 2023-05-11 | -$39.33M derived: sum of 2 quarters · filed 2023-05-11 | -$57.27M derived: sum of 3 quarters · filed 2023-05-11 | -$74.66M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$17.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | -$35.64M derived: sum of 2 quarters · filed 2023-03-28 | -$53.03M derived: sum of 3 quarters · filed 2023-03-28 | -$62.66M 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | -$17.93M 10-Q · filed 2022-11-10 | -$35.32M derived: sum of 2 quarters · filed 2022-11-10 | -$44.95M 10-Q · filed 2022-11-10 | -$55.32M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | -$17.39M 10-Q · filed 2022-08-11 | -$27.02M 10-Q · filed 2022-08-11 | -$37.39M derived: sum of 3 quarters · filed 2022-08-11 | -$37.70M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$9.63M 10-Q · filed 2022-05-12 | -$20.00M derived: sum of 2 quarters · filed 2022-05-12 | -$20.30M derived: sum of 3 quarters · filed 2022-05-12 | -$20.34M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$10.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$10.68M derived: sum of 2 quarters · filed 2022-03-29 | -$10.71M derived: sum of 3 quarters · filed 2022-03-29 | -$10.71M 10-K · filed 2022-03-29 | ||||
| 2020-09-30 | -$305.00K 10-Q · filed 2021-11-12 | -$440.39K 10-Q · filed 2020-11-10 | -$338.00K derived: sum of 2 quarters · filed 2021-11-12 | -$342.00K 10-Q · filed 2021-11-12 | ||||
| 2020-06-30 | -$33.00K 10-Q · filed 2021-08-12 | -$37.00K 10-Q · filed 2021-08-12 | -$173.00K 10-K · filed 2020-09-23 | |||||
| 2020-03-31 | -$4.00K 10-Q · filed 2021-05-17 | -$38.59K 10-Q · filed 2020-05-06 | -$39.12K 10-Q · filed 2020-05-06 | |||||
| 2019-12-31 | -$45.00K 10-K/A · filed 2021-05-14 | |||||||
| 2019-09-30 | -$100.00 10-Q · filed 2020-11-10 | -$100.00 derived: sum of 2 quarters · filed 2020-11-10 | -$1.55K derived: sum of 3 quarters · filed 2020-11-10 | |||||
| 2019-06-30 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2020-09-23 | -$1.45K 10-K · filed 2020-09-23 | ||||||
| 2019-03-31 | -$1.45K 10-Q · filed 2020-05-06 |